<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for MYL</title>
    <link />
    <description>Headlines for Mylan Inc.</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>Actavis - A Potential Deal With Warner Chilcott Would Further Spur Interest In Actavis Itself</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1438941-actavis-a-potential-deal-with-warner-chilcott-would-further-spur-interest-in-actavis-itself.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 16 May 2013 00:35:35 GMT</pubDate>
    </item>
    <item>
      <title>Novartis Considers Possible Bid for Actavis</title>
      <link>http://www.fool.com/news/xt/smartmoney/www.smartmoney.com/news/on/.aspx?story=on-20130515-000691&amp;cid=1244&amp;source=itxwebtxt0000015</link>
      <author>Smart Money</author>
      <pubDate>Wed, 15 May 2013 18:45:00 GMT</pubDate>
    </item>
    <item>
      <title>Mylan: Solid Results Despite Revenue Miss</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1436941-mylan-solid-results-despite-revenue-miss.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 15 May 2013 13:15:30 GMT</pubDate>
    </item>
    <item>
      <title>Benzinga's M&amp;A Chatter for Tuesday May 14, 2013</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/05/3589564/benzingas-m-a-chatter-for-tuesday-may-14-2013.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Tue, 14 May 2013 18:01:53 GMT</pubDate>
    </item>
    <item>
      <title>Mylan Becomes #17 Most Shorted Nasdaq 100 Component, Replacing Akamai Technologies</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11920427/1/mylan-becomes-17-most-shorted-nasdaq-100-component-replacing-akamai-technologies.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Fri, 10 May 2013 15:28:00 GMT</pubDate>
    </item>
    <item>
      <title>Billionaire John Paulson's Long-Term Stock Picks</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1408691-billionaire-john-paulson-s-long-term-stock-picks.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 07 May 2013 10:57:08 GMT</pubDate>
    </item>
    <item>
      <title>Valeant Misses Earnings and Revenue Estimate in 1Q (Revised) - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/98796/valeant-misses-earnings-and-revenue-estimate-in-1q-revised.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Tue, 07 May 2013 08:27:01 GMT</pubDate>
    </item>
    <item>
      <title>Valeant Beats Earnings, Misses Revs - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/98610/valeant-beats-earnings-misses-revs.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Fri, 03 May 2013 13:05:01 GMT</pubDate>
    </item>
    <item>
      <title>Mylan Reports in line Earnings - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/98558/mylan-reports-in-line-earnings.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Fri, 03 May 2013 07:55:01 GMT</pubDate>
    </item>
    <item>
      <title>Mylan Management Discusses Q1 2013 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1397171-mylan-management-discusses-q1-2013-results-earnings-call-transcript.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 02 May 2013 21:10:13 GMT</pubDate>
    </item>
    <item>
      <title>US Stock Futures Up; GM Earnings, Economic Data In Focus</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/05/3551509/us-stock-futures-up-gm-earnings-economic-data-in-focus.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Thu, 02 May 2013 05:51:34 GMT</pubDate>
    </item>
    <item>
      <title>Earnings Scheduled For May 2, 2013</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/earnings/13/05/3551422/earnings-scheduled-for-may-2-2013.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Thu, 02 May 2013 04:16:33 GMT</pubDate>
    </item>
    <item>
      <title>Why Raptor Pharmaceuticals Shares Spiked and Then Dropped</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/04/30/why-raptor-pharmaceuticals-shares-spiked-then-drop/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Tue, 30 Apr 2013 18:25:00 GMT</pubDate>
    </item>
    <item>
      <title>Orphan Drug Status for Teva/Xenon Drug - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/98089/orphan-drug-status-for-teva-xenon-drug.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Fri, 26 Apr 2013 15:44:01 GMT</pubDate>
    </item>
    <item>
      <title>Mylan Shows Great Potential For Growth</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1360121-mylan-shows-great-potential-for-growth.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 22 Apr 2013 23:22:17 GMT</pubDate>
    </item>
    <item>
      <title>Favorable Court Ruling for Actavis - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/97518/favorable-court-ruling-for-actavis.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Fri, 19 Apr 2013 17:45:01 GMT</pubDate>
    </item>
    <item>
      <title>Data on Teva's Milprosa - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/97405/data-on-tevas-milprosa.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Thu, 18 Apr 2013 18:20:01 GMT</pubDate>
    </item>
    <item>
      <title>Teva More Undervalued Than Mylan, Looks Towards Technology</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1350061-teva-more-undervalued-than-mylan-looks-towards-technology.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 18 Apr 2013 05:56:22 GMT</pubDate>
    </item>
    <item>
      <title>Still Neutral on Mylan - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/97093/still-neutral-on-mylan.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Mon, 15 Apr 2013 17:20:01 GMT</pubDate>
    </item>
    <item>
      <title>Good News for Warner Chilcott - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/97088/good-news-for-warner-chilcott.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Mon, 15 Apr 2013 16:50:01 GMT</pubDate>
    </item>
  </channel>
</rss>
